Skip to content

Guardant Health to Present 38 Abstracts at 2026 ASCO Annual Meeting

Guardant Health, a precision oncology company, will showcase 38 abstracts and an oral presentation in collaboration with Pfizer during the ASCO Annual Meeting, highlighting advancements in methylation-based tumor classification and liquid biopsy technology from May 29 to June 2, 2026.

PALO ALTO, Calif.–(BUSINESS WIRE)—- $GH–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstracts, as well as one oral presentation in partnership with Pfizer, showcasing advances in methylation-based tumor classification and liquid biopsy technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois taking place May 29 – June 2, 2026. Key data that will be prese